Table 2.
Group I (n=70) |
Group II (n=70) |
Group III (n=70) |
|
Pulmonary vein antrum isolation | 70 (100%) | 70 (100%) | 70 (100%) |
Cavo-tricuspid isthmus linear ablation | 12 (17%) | 12 (17%) | 18 (26%) |
Supra vena cava isolation | 3 (4%) | 7 (10%) | 6 (9%) |
Left atrial posterior wall isolation | 1 (1%) | 5 (7%) | 56 (80%) * |
Mitral isthmus linear ablation | 2 (3%) | 3 (4%) | 4 (6%) |
Low voltage zone modification | 2 (3%) | 0 (0%) | 1 (1%) |
Other atrial tachycardia | 2 (3%) | 2 (3%) | 5 (7%) |
Procedure time (min) | 251±53 | 250±58 | 188±38 † |
Fluoroscopic time (min) | 25.1±10.0 | 15.1±7.3 * | 13.0±5.4 * |
Radiation dose (mGy) | 295.0±263.0 | 109.6±103.5 * | 110.1±89.6 * |
3D-EMS (CARTO/Ensite/Rhythmia) | 64/6/0 | 46/24/0 ‡ | 31/38/1 * |
Contact force monitoring catheter | 64 (91%) | 46 (66%) ‡ | 69 (99%) |
*p<0.0001.
†p=0.002.
‡p=0.0003.
3D-EMS, three-dimensional electroanatomical mapping systems.